Primary Intraocular Non-Hodgkin Lymphoma

Primary Intraocular Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

71 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 2
Ph III recruiting: 1
Growth YoY: —
Industry share: 33%
Top sponsor: Aldeyra Therapeutics, Inc.
Termination share: 30.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06973811	ZR-MTX for PIOL Phase II Trial(ZR-MTX)	recruiting	Phase 2	47	Peking Union Medical College HospitalOTHER	1	Sep 4, 2026	clinicaltrials
NCT01815749	Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma	active not recruiting	Phase 1	30	City of Hope Medical CenterOTHER	1	Jun 25, 2026